October 10, 2019
Amneal launches generic Invega
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), has launched its generic version of Invega® (paliperidone) extended-release tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg.
Pharmaceuticals, Biotechnology and Life Sciences
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), has launched its generic version of Invega® (paliperidone) extended-release tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg.
Allergan plc announced on Friday that it has launched a generic version of Janssen’s Invega (paliperidone extended-release tablets) in the…